Diploma di Formazione Manageriale per Direttore responsabile di Struttura Complessa presso l'Alta scuola di economia e management dei sistemi sanitari di Roma
Studio clinico -“A Phase 1/2 Study of ARQ 092 in Patients with Overgrowth Diseases and Vascular Anomalies with Genetic Alterations of the PI3K/AKT Pathway” - Coinvestigatrice
Studio clinico - “Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel Group Study to Characterize the Efficacy, Safety, and Tolerability of 24 Weeks of Evolocumab for Low Density Lipoprotein-cholesterol (LDL-C) Reduction, as Add-on to Diet and Lipid-lowering Therapy, in Pediatric Subjects 10 to 17 Years of Age With Heterozygous Familial Hypercholesterolemia (HeFH)” - Coinvestigatrice
Studio clinico - “A Randomized, Double-Blind, Placebo-Controlled Study Followed by an Open Label Treatment Period to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents with Heterozygous Familial Hypercholesterolemia” - Coinvestigatrice
Studio clinico - “Phase III, Single-arm, Open-label, International, Multi-centre Study to Evaluate the Efficacy and Safety of Lomitapide in Paediatric Patients with Homozygous Familial Hypercholesterolaemia (HoFH) on Stable Lipid-lowering Therapy” - Coinvestigatrice
Studio clinico - EPIK-P2: A Phase II double-blind study with an upfront, 16-week randomized, placebo-controlled period, to assess the efficacy, safety and pharmacokinetics of alpelisib (BYL719) in pediatric and adult patients with PIK3CA-related overgrowth spectrum (PROS) - Coinvestigatrice
Studio clinico - Two part (double-blind inclisiran versus placebo [Year 1] followed by open-label inclisiran [Year 2]) randomized multicenter study to evaluate safety, tolerability, and efficacy of inclisiran in adolescents (12 to less than 18 years) with heterozygous familial hypercholesterolemia and elevated LDL-cholesterol (ORION-16) - Coinvestigatrice
Ricerca corrente Ipersecrezione di GH nei pazienti con Glioma delle vie ottiche e Neurofibromatosi tipo 1; 2016 - Coinvestigatrice
Studio Plasminogen in Ligneous conjunctivitis; Compassionate use - Coinvestigatrice
Ricerca finalizzata CCM Revisione sistematica per progetto di: Macchiaiolo M, Maraschini A, Mastroiacovo P. The folic acid supplementation during periconceptional period has a protective effect on prevention of oral clefts? A systematic review Revisione sistematica prodotta su commissione del progetto “Implementazione di strategie utili favorire l’assunzione ottimale di acido folico nelle donne in età fertile del Centro Nazionale per la prevenzione e controllo delle malattie (CCM) - Coordinatrice
